Cellular Orthopedics Blog
Regenerative Medicine Fact Check or Cellular Orthopedic Q&A
Question: Dr. Sheinkop, three months ago you did an A2M intervention on a 72- year old athletic man with progressive limitations from an arthritic knee. You reported how he was doing at six weeks, how is he doing at 12 weeks? Answer: Hi. I trust all is well with...
100th Publication on Evidence Based Regenerative Medicine and Cellular Orthopedics
“Article Title: Clinical outcomes and safety of a combined autologous bone marrow concentrate intraosseous and intraarticular injection for knee osteoarthritis at 12 months Journal Title: Journal of Regenerative Medicine Dear Dr. Sheinkop I am pleased to tell you that...
Why We Age and Why We Don’t Have To
Is the subtitle of Lifespan, a book written by David A. Sinclair, PhD, and published by ATRIA BOOKS in 2019. While my weekly blogs are focused on Conservative, Preservative and Restorative measures for osteoarthritis, what if aging itself is a disease and that disease...
A Patient Testimonial for Growth Factors
At times, my blog is based on statistically documented evidence concerning Cellular Orthopedic interventions. To date, that’s how I treat patents, evidence based regenerative medicine. This time though, I found an unsolicited testimonial so compelling that I am...
Your Journey with an Arthritic Joint
Better stated, how do you bridge the gaps in the continuum of joint care from early intervention to joint replacement? Arthritic Joint Pain Management First and foremost, our goal is functional restoration and maintenance, relieving symptoms, and postponing, perhaps...
Alpha 2 Macroglobulin Injections – A2M: A Treatment for Arthritis?
On Wednesday, I am clinically testing Alpha 2 macroglobulin, or A2M. My first patient is the product distributor; he is my guinea pig. Supposedly the injection will stop cartilage breakdown in joints, promote tissue growth and support the overall restoration of an...
What is A2M and Exosomes?
This is a cytokine that may neutralize some of the breakdown molecules in degenerating joints. It is found in the circulating blood plasma. There is a centrifuge on the market that can concentrate Alpha 2 Macroglobulin (A2M) from blood, and many doctors who use it...
Regenerative Medicine, Stem Cells, and Orthobiologic Update
We certainly are living in changing times and daily uncertainties, but my practice continues. Over the years, I have noted that when there is public angst, I have a bit freer time to review our outcomes. Alfred E. Neuman, the mascot for Mad Magazine during its heyday,...
An Orthobiologic Update
The TOBI meeting was held June 12 and 13. Annually, it is the largest gathering of physicians who dedicate their practices to Regenerative Medicine. I have been contributing yearly to the scientific program almost since its inception; and I did so again this year. The...
‘Personalized Stem Cells’ Trial Update and More
“They are close to reaching the max number in the study and feel they have enough data at this point.” While we still could offer adipose derived stem cells to patients via Liposuction and processing of the adipose tissue to recover millions of stem cells, the...
Scientific Evidence Supporting Cellular Orthopedic Recommendations
In my last blog, I used anecdote and two patient experiences to justify my treatment recommendations. This blog will feature a scientific and statistically significant outcomes study that I will be presenting next week at the Orthobiologic Institute Symposium (TOBI)...
Stem Cell Patient Outcome Anecdotes
There are statistics and anecdotes that are used to review the outcomes of a particular cellular orthopedic treatment option and help determine what is best for a patient with arthritis. At times, it is difficult, and even impossible, to develop a sufficient number of...